Among the Finnish chemical industry, the pharmaceutical industry was the exports growth driver sector as shown by the financial review published by the Chemical Industry Federation this month.
Between January and August, medicine exports grew by 4% compared with the same period in the preceding year, according to a web posting by the trade group Pharma Industry Finland (PIF).
The pharmaceutical industry accounts for a larger proportional share due to both its own growth in terms of euro and the decrease in the export of other chemical industry product sectors. In the first part of the year, the pharmaceutical industry exports rose to over 650 million euros ($692 million), representing about 10% of the aggregate chemical industry exports. The annual added value generated by the pharmaceutical industry has grown to 1.3 billion euros, which represents almost 30% of the total valued added of the chemical industry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze